RLMD Stock Analysis: Buy, Sell, or Hold?
RLMD - Relmada Therapeutics, Inc. Common Stock
$6.38
-0.05 (-0.78%)
▼
5d:
+8.87%
30d:
+39.91%
90d:
+41.46%
WAIT
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Accumulation
RLMD is down 5.4% this week, but smart money is accumulating calls. Top strike: $7.5 2026-05-15 with 512 OI. Call ratio: 100% View Scanner →
Strength: 7.7/10
Get Alerted When RLMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: RLMD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: RLMD shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: RLMD is currently trading at $6.38, which is considered extended relative to its 30-day fair value range of $4.33 to $6.37.
Technical Outlook: Technically, RLMD is in a uptrend. Immediate support is located at $5.68, while resistance sits at $6.74.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $5.50. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RLMD is in a uptrend. Immediate support is located at $5.68, while resistance sits at $6.74.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $5.50. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$4.33 -
$6.37
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
40.5%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 14.5% above Wall St target ($5.50)
Fair Price Analysis
30-Day Fair Range
$4.33 -
$6.37
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$5.68
Resistance Level
$6.74
Current Trend
Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-17.86
Wall Street Target
$5.50
(-14.5%)
Share & Embed Analysis
Last updated: March 30, 2026 3:07 PM ET
Data refreshes hourly during market hours. Next update: 4:07 PM
Data refreshes hourly during market hours. Next update: 4:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLMD showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Maged Shenouda
BUY
11665 shares
2025-12-15
Chuck Ence
BUY
136000 shares
2025-11-05
Maged Shenouda
BUY
500000 shares
2025-11-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 52 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$33 | 49 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 57 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$43 | 56 HOLD |
